학술논문
Lack of difference between nebivololhydrochlorothiazide and metoprololhydrochlorothiazide on aortic wave augmentation and central blood pressure
Document Type
Article
Author
Source
Journal of Hypertension; December 2013, Vol. 31 Issue: 12 p2447-2454, 8p
Subject
Language
ISSN
02636352; 14735598
Abstract
The vasodilating beta-blocker nebivolol is thought to be superior in lowering wave reflection and central blood pressure (BP) compared to nonvasodilating beta-blockers. The results from studies comparing nebivolol with either metoprolol or atenolol, with or without hydrochlorothiazide (HCTZ), are not unequivocal.